Navigation Links
Huntington Area Development Council Attracts Technology-Based Startup Companies With $150,000 Grant From Verizon West Virginia
Date:11/25/2008

Grant to Support Council's Biotech Incubator on MarshallUniversity's Campus

HUNTINGTON, W. Va.,Nov. 25/PRNewswire/ -- In an effort to attract new biotechnology companies and assist them in bringing new ideas and products to market quickly and efficiently, the Huntington Area Development Council (HADCO) is creating a biotech incubator with the help of a $150,000 grant from Verizon West Virginia.

The incubator, which will be located on Marshall University's campus, will be completed in May 2009.

"Technology is important to West Virginia's continued growth and future success," said Gerald L. McDonald, president of HADCO. "Through the biotech incubator, our goal is to provide seamless support for biotech startups and create new, technology-based jobs for our area. Our partnership with Verizon will help make this happen."

Verizon's grant will help offset the costs for startup biotech companies to receive consulting on technology planning and market research, along with technical assistance related to testing the commercial viability of emerging biotech products and services.

B. Keith Fulton, president of Verizon West Virginia, said, "Verizon has been a leading proponent of economic development in Huntington and West Virginia for more than 20 years. By partnering with organizations like HADCO to improve the communities we serve, we are helping to create a diversified, forward-looking economy where entrepreneurs can succeed.

"Once these new businesses are in the incubator, HADCO and Marshall University will support them as they focus on getting their ideas to market," said Fulton. "That will help these businesses grow and create jobs right here at home."

About the Huntington Area Development Council

HADCO is a nonprofit economic development organization whose mission
'/>"/>

SOURCE Verizon
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Medivation Receives Corporate Achievement Award From Huntingtons Disease Society of America
2. Repligen Announces Publication of Positive Results with Proprietary HDAC Inhibitor in Huntingtons Disease Model
3. HDSA-San Diegos Team 2CureHD Continues its Race to Cure Huntingtons Disease
4. Raptor Pharmaceuticals Corp. Receives FDA Orphan Drug Designation for Cysteamine in Huntingtons Disease
5. Avicenas HD-02 to Proceed to NIH Sponsored Phase III Huntingtons Disease Trial
6. DuPont Opens Research & Development Center in India
7. National Drug Development Accelerator Launched
8. Transgenomic Awarded SBIR Grant to Support Development of SURVEYOR(R) Endonuclease Adaptor-ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation
9. China Medical Technologies Completes the Development of EGFR Molecular Diagnostic Kits
10. Debiopharm and Aurigene Sign Licensing Agreement for the Development and Commercialisation of Debio 0617, a Novel Inhibitor of an Undisclosed Oncology Pathway
11. Med Discovery and Laborium Biopharma Sign a Bioprocess Development Partnership Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Bed bugs compromised Penn State. A report ... Meanwhile, My Cleaning Products offered complimentary samples of its bed ... without using harmful chemical elements. , Based on the ... building was actually a dormitory , My Cleaning Products ... May 13 and bed bug presence was confirmed on May ...
(Date:5/23/2013)... DE (PRWEB) May 23, 2013 Just released ... by executive coach and author Barbara Roche: “Commit to Confidence: ... Out.” , Filled with helpful tips and quotes from the ... business leaders, and tangible exercises that readers can do on ... how to achieve their personal and professional goals. ...
(Date:5/22/2013)... 22, 2013 iLuv Creative Technology, the ... for the mobile lifestyle, announces they are now shipping ... manage multiple iPad devices efficiently. Winner of the 2013 ... Good Design award, MultiCharger-X is revolutionizing the way businesses, ... is deployed. , MultiCharger-X (iAD910) combines ...
(Date:5/22/2013)... May 22, 2013   Oligomerix, Inc. , ... disease modifying therapeutics for Alzheimer,s disease (AD) and ... its Series B financing, which includes both issuance ... would represent approximately $2.8M in new investments in ... supported the raise. Funding from ...
Breaking Biology Technology:Penn State Dorm Infested with Bed Bugs, My Cleaning Products Offers Complimentary Sample of Bed Bug Spray to Help Bed Bug Victims 2iLuv Now Shipping the All New MultiCharger-X 2iLuv Now Shipping the All New MultiCharger-X 3Oligomerix, Inc. Completes Series B Financing 2Oligomerix, Inc. Completes Series B Financing 3
... Uroplasty, Inc. (Amex:,UPI) announced today that it will ... on Monday, November 10, 2008 at the New York,Palace ... Chief Executive,Officer and Medi Jiwani, Vice President and Chief ... financial,performance at 4:55 p.m. Eastern Time., Attendance at ...
... DIEGO, Nov. 4 ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ... of ADVENTRX, is scheduled to present at the Rodman ... scheduled to present,on Tuesday, November 11th, 2008 at 2:50 ... place November 10-12, 2008 at the,Palace Hotel in New ...
... technology is one of the rapidly growing markets in life science ... is projected to reach $2.2 billion. Major factors that continue to ... the existing and emerging technologies. , ... San Jose, ...
Cached Biology Technology:Uroplasty to Present at the Rodman & Renshaw 10th Annual Healthcare Conference in New York 2World Gene Amplification Technologies Market to Reach $2.2 Billion by 2015, According to New Report by Global Industry Analysts, Inc. 2World Gene Amplification Technologies Market to Reach $2.2 Billion by 2015, According to New Report by Global Industry Analysts, Inc. 3
(Date:5/23/2013)... unnecessarily undergo surgery or harsh treatments because science ... aggressive forms of the disease. Researchers at Case ... are developing technology that allows patients to safely ... treatments or take drastic measures. , The project ... professor of biomedical engineering at Case Western Reserve ...
(Date:5/23/2013)... have succeeded in treating cerebral palsy with autologous cord ... a 2.5 year old boy had been in a ... Just two months after treatment with the cord blood ... following months, the child learned to speak simple sentences ... a Korean study, dispel the long-held doubts about the ...
(Date:5/23/2013)... world,s largest and fastest growing open-access publishers, announces ... in Bioengineering and Biotechnology . , A ... in Bioengineering and Biotechnology will provide a ... and biotechnology research to be disseminated and discussed. ... will provide an open-science and interactive web ...
Breaking Biology News(10 mins):Using big data to identify prostate cancers and best treatments 2Using big data to identify prostate cancers and best treatments 3First successful treatment of pediatric cerebral palsy with autologous cord blood 2Frontiers launches new open-access journal in Bioengineering and Biotechnology 2
... tripled in the last 25 years, putting many children at ... in Academic Pediatrics by an obesity expert at ... Center. "Children are not only becoming obese, but ... Skelton, M.D., lead author and director of the Brenner FIT ...
... Many experimental studies have found that physical exercise ... risks of cardiovascular disease; however, few of these ... ethnic breakdowns. Now, a long-term study of over ... gender- specific data on the cholesterol effects of ...
... from CSIRO,s Food Futures Flagship have made a breakthrough ... noses, (e-noses) by developing a system for comparing their ... fly. "Although e-noses already have many uses such ... air quality they are not as discriminating as ...
Cached Biology News:Research shows rates of severe childhood obesity have tripled 2Health benefits of physical activity more pronounced in women 2E-Noses: Testing their mettle against fly noses 2
Mouse monoclonal antibody raised against a partial recombinant ALAS2. NCBI Entrez Gene ID = ALAS2...
96-well format (For processing samples on microplate-size MALDI target plates such as those from Bruker, Shimadzu, Thermo, and PerkinElmer) Packaging: 2 / pack...
Mouse monoclonal antibody raised against a partial recombinant CENTB2. NCBI Entrez Gene ID = CENTB2...
...
Biology Products: